Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report03 June 2024
After nearly 15 years on the Urenco Ltd Board, Stephen Billingham will step down as Chairman and a director at the end of his current term on 30 June 2024.
Stephen has been Chairman since 2016 and, prior to that, a UK Government appointed non-executive director. He has been one of the longest serving directors in the company’s history and has attended nearly 100 Board meetings since 2009.
Commenting on his departure, Stephen said: “It has been a great privilege to be involved in such a special and important company for so long. I joined at a time of production expansion and leave when Urenco is once again boosting its capacity. Urenco is more important to the world now than at any time in its history and has an essential role to play in providing reliable low carbon energy. I thank everyone at Urenco for their support over the years and I have been proud to have played a small part in Urenco’s success.”
Boris Schucht, Urenco CEO, added: “On behalf of the company and the Board I would like to thank Stephen for his long-term service to Urenco. He has made a huge contribution, in both positive and more challenging times, showing great leadership and ensuring Urenco continues to go from strength to strength.”
The approvals for the appointment of Stephen’s successor as Chairman are in their final stages and an announcement is expected shortly.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries